Some current approaches to the treatment of patients with trophic ulcers in postthrombotic syndrome
DOI:
https://doi.org/10.11603/1811-2471.2015.v23.i2-3.5218Abstract
SUMMARY. This article describs the new view of anintegrated approach to the treatment of patients with trophic ulcers in postthrombotic syndrome by influencing main pathogenic mechanismsus in combination therapy to improve the effectiveness of healing.
KEY WORDS: postthrombotic syndrome, venous ulcer, quercetin, arginine.
References
Arhynyn v medytsynskoy praktyke / YU. M. Stepanov, Y. N. Kononov, A. Y. Zhurbyna, A. YU. Fylyppova // Suchasna hastroenterolohiya. – 2005. – № 4 (24). – S. 121–127.
Butov D.O. Efektyvnistʹ kompleksnoho likuvannya khvorykh na vpershe diahnostovanyy destruktyvnyy tuberkulʹoz lehenʹ iz vykorystannyam kvertsetynu z polivinilpirolidonom : avtoref. dys. Na zdobuttya naukovoho stupenya kand. med. nauk : 14.01.26 / D.O. Butov / Nats. in-t ftyziatriyi i pulʹmonolohiyi im. F.H.Yanovsʹkoho AMN Ukrayiny. – K., 2010. – 20 s.
Vanyn A. F. Oksyd azota rehulyator kletochnoho metabolyzma / A. F. Vanyn // Sorosovskyy obrazovatelʹnyy zhurnal. – 2001. – T. 7, №11. – S. 7–12.
Yvashkyn V. T. Oksyd azota v rehulyatsyy funktsyonalʹnoy aktyvnosty fyzyolohycheskykh system / V. T. Yvashkyn, O. M. Drapkyna // Ross. zhurn. hastroénterol., hepatol. y koloproktol. – 2000. – № 4. – S. 16–21.
Maksymiv O. O. Efektyvnistʹ zastosuvannya kvertsetynu yak terapiyi suprovodu pry protezuvanni povnymy znimnymy protezamy u khvorykh na tsukrovyy diabet 2-ho typu / O.O. Maksymiv // Bukovynsʹkyy medychnyy visnyk. – 2014. – T. 18, № 4 (72). – S. 73–77.
Post-thrombotic syndrome: a clinical review /Baldwin M. J., Moore H. M., Rudarakanchana N. [et al.] // J.Thromb.Haemost.– 2013. – № 11. – R. 795.
Relation between quality of anticoagulant treatment and the development of the postthrombotic syndrome/ Dongen C. J., Prandoni P., Frulla M. [et al.] // J. Thromb. Haemost. – 2005. – № 3. – R. 939–42.
Effect of the flavonoid quercetin on inflammation and lipid peroxidation induced by Helicobacter pylori in gastric mucosa of guinea pig / R. González-Segovia, J.L. Quintanar, E. Salinas [et al.] // J. Gastroenterol. – 2008. – Vol. 43. – P. 441–447.
Flavonoid intake and coronary mortality in Finland: a cohort study / P. Knekt, R. Jarvinen, A. Reunanen, J. Maatela // BMJ. – 1996. – Vol. 312. – P. 478–481.
Magier D., MacKinnon B., Gent M. Prevention and treatment of postphlebitic syndrome: results of a 3-part study /Ginsberg J., Hirsh J., Julian J., Vander L.M.[et al.] //Arch. Intern. Med. – 2001. – № 161. – R. 2105–2109.
Immune and metabolic effects of arginine in the surgical patient / J. M. Daly, J. Reynolds, A. Thorn [et al.] // Ann. Surgery.–1988.– Vol. 206, № 4. – P. 512–523.
Ingestion of quercetin inhibits platelet aggregation and essential components of the collagen-stimulated plateletactivation pathway in humans / G.P. Hubbard, S. Wolffram, J.A. Lovegrove, J.M. Gibbins // J. Thromb. Haemost. – 2004. – Vol. 2. – P. 2138–2145.
Definition of post-thrombotic syndrome of the leg for use in clinical investigations: a recommendation for standardization / Kahn S. R., Partsch H., Vedantham S. [et al.] // J ThrombHaemost. – 2009. – № 7. – R. 879.
Neglen P. Invasive treatment of post-thrombotic syndrome // P. Neglen // Phlebolymphology. – 2006. – № 13. – R. 163–171.
Quercetin inhibits lymphocyte activation and proliferation without inducing apoptosis in peripheral mononuclear cells / E. Lugli, R. Ferraresi, E. Roat [et al.] // Leukemia Research. – 2009. – Vol. 33. – P. 140–150.
